相关实验视频

Updated: Aug 15, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

乳腺癌中的多组基因分析:用于推进诊断和临床护理的实用性

Emna El Gazzah^1,2, Scott Parker^1,2, Mariaelena Pierobon^1,2

¹School of Systems Biology, George Mason University, Manassas, VA, USA.

Expert review of molecular diagnostics

|April 7, 2025

概括

多原子研究提供了对乳腺癌分子格局的全面了解,改善了诊断和治疗选择. 整合多omics和AI是推动个性化乳腺癌护理和患者结果的关键.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
蛋白质组学是指蛋白质组学.
文字转录学 (Transcriptomics) 是一个学科.

背景情况:

乳腺癌是全球重要的健康问题.
单个米的方法提供了对复杂的乳腺癌生物学有限的理解.
精确瘤学已经改善了结果,但依赖于碎片化的分子数据.

研究的目的:

审查乳腺癌多原子研究的进展.
展示多原子集成如何增强对分子变化和后果的理解.
突出多学科和人工智能在精确诊断和治疗选择中的作用.

主要方法:

对乳腺癌近期的多原子研究进行了回顾.
对临床数据的分析,以说明多组合组合的好处.
在多原子数据分析中探索人工智能 (AI) 应用.

主要成果:

多原子集成提供了对乳腺癌分子驱动因素的整体观点.
与人工智能相结合的多态学可以改进预后模型和治疗策略.
克服成本和数据复杂性等挑战对于临床实施至关重要.

结论:

多原子研究和人工智能对于推进个性化乳腺癌治疗至关重要.
通过多omics提高理解,导致改善患者的治疗结果.
标准化和数据集成对于实现瘤学多种病理的全部潜力至关重要.

关键词:

乳腺癌是什么? 乳腺癌是什么多种主题的多种主题.个性化医疗是个性化的医疗.精确瘤学精确瘤学翻译研究是翻译研究.

更多相关视频

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...